Overview
- 22 inspections across 21 sites are on record.
- 47 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-06-20.
At a glance
Inspections
22
Sites
21
Observations
47
Career since
Jun 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Flamma USA LLC | 20 Jun 2025 | Human Drugs | On file |
| Mylan Laboratories Limited | 17 May 2024 | Human Drugs | View 483 → |
| Alaina Healthcare Private Limited | 3 May 2024 | Human Drugs | On file |
| IntegraDose Compounding Services LLC | 1 Mar 2024 | Human Drugs | View 483 → |
| Aurora Pharmaceutical, Inc., DBA Jefferson Labs | 19 Jan 2024 | Human Drugs |
Sites inspected
Flamma USA LLCMalvern, United States1 insp.
Mylan Laboratories LimitedHosur, India1 insp.
Alaina Healthcare Private LimitedBaddi, India1 insp.
IntegraDose Compounding Services LLCShoreview, United States1 insp.
Aurora Pharmaceutical, Inc., DBA Jefferson LabsNorthfield, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Ross J Grigsby4 shared
Soyinka S Eneng3 shared
Timothy H Vo3 shared
Patty P Kaewussdangkul2 shared
Alan P Kurtzberg2 shared
Karthik M Krishnan1 shared
Beatrix D Hippe1 shared
Beatrix D Arevalo1 shared
Melissa M Steiger1 shared
Robert J Ham1 shared
Full investigator report
Get the verbatim findings behind Kevin P Regan's 47 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site